Oct4 promoted proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in colon cancer cells by activating the SCF/c-Kit signaling pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics. 2018;68:7–30. DOI:10.3322/caac.21442
   Google Scholar
• Labianca R, Beretta GD, Kildani B, et al. Colon cancer. Crit Rev Oncol Hematol. 2010;74:106–133.
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713–732.
   PubMed Web of Science ®Google Scholar
• Nfonsam VN, Jecius H, Chen D, et al. Increasing incidence of colon cancer in the young: assessing the tumor biology. J Am Coll Surg. 2019;229:79–90.
   PubMed Web of Science ®Google Scholar
• Rumgay H, Shield K, Charvat H, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 2021;22:1071–1080.
   PubMed Web of Science ®Google Scholar
• Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002;31:925–943.
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw. 2018;16:359–369.
   PubMed Web of Science ®Google Scholar
• Mody K, Bekaii-Saab T. Clinical trials and progress in metastatic colon cancer. Surg Oncol Clin N Am. 2018;27:349–365.
   PubMed Web of Science ®Google Scholar
• Freeman HJ. Early stage colon cancer. World J Gastroenterol. 2013;19:8468–8473. DOI:10.3748/wjg.v19.i46.8468
   Google Scholar
• Sohn EJ, Moon HJ, Lim JK, et al. Regulation of the protein stability and transcriptional activity of OCT4 in stem cells. Adv Biol Regul. 2021;79:100777.
   PubMedGoogle Scholar
• Mohiuddin IS, Wei SJ, Kang MH. Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochimica et Biophysica Acta Mol Basis Dis. 2020;1866:165432.
   PubMed Web of Science ®Google Scholar
• Lengner CJ, Welstead GG, Jaenisch R. The pluripotency regulator Oct4: a role in somatic stem cells? Cell Cycle (Georgetown, Tex). 2008;7:725–728. DOI:10.4161/cc.7.6.5573.
   PubMed Web of Science ®Google Scholar
• Liang C, Xu Y, Ge H, et al. Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis. Onco Targets Ther. 2018;11:47–57.
   PubMed Web of Science ®Google Scholar
• Lu CS, Shiau AL, Su BH, et al. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer. 2020;13:62. DOI:10.1186/s13045-020-00887-1
   Google Scholar
• Lu H, Xie Y, Tran L, et al. Chemotherapy-Induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness. J Clin Invest. 2020;130:4607–4623.
   PubMed Web of Science ®Google Scholar
• Jiang WL, Zhang PF, Li GF, et al. Oct-4 is associated with gastric cancer progression and prognosis. Onco Targets Ther. 2016;9:517–522.
   PubMed Web of Science ®Google Scholar
• Zhao X, Lu H, Sun Y, et al. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: a meta-analysis. 2020;99:e22804. DOI:10.1097/md.0000000000022804
   Google Scholar
• Chen Z, Zhang L, Zhu Q, et al. Clinical value of octamer-binding transcription factor 4 as a prognostic marker in patients with digestive system cancers: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32:567–576.
   PubMed Web of Science ®Google Scholar
• Du Z, Lovly CM. Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer. 2018;17:58.
   PubMed Web of Science ®Google Scholar
• Lennartsson J, Rönnstrand L. Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev. 2012;92:1619–1649.
   PubMed Web of Science ®Google Scholar
• Su B, Huang T, Jin Y, et al. Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways. Gastric Cancer. 2021;24:352–367.
   PubMed Web of Science ®Google Scholar
• Annese T, Tamma R, Bozza M, et al. Autocrine/paracrine loop between SCF(+)/c-Kit(+) mast cells promotes cutaneous melanoma progression. Front Immunol. 2022;13:794974.
   PubMed Web of Science ®Google Scholar
• Tonary AM, Macdonald EA, Faught W, et al. Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis. Int J Cancer. 2000;89:242–250.
   PubMed Web of Science ®Google Scholar
• Liang J, Wu YL, Chen BJ, et al. The C-kit receptor-mediated signal transduction and tumor-related diseases. Int J Biol Sci. 2013;9:435–443.
   PubMed Web of Science ®Google Scholar
• Hu J, Li J, Yue X, et al. Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes. Oncotarget. 2017;8:28463–28470.
   PubMedGoogle Scholar
• Wang QH, Zhang M, Shi CT, et al. High Oct4 predicted worse prognosis of right-sided colon cancer patients. Future Oncol. 2018;14:2279–2291.
   PubMed Web of Science ®Google Scholar
• Jen J, Tang YA, Lu YH, et al. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression. 2017;16:104. DOI:10.1186/s12943-017-0674-z
   Google Scholar
• Liu X, Ma M, Duan X, et al. Knockdown of OCT4 may sensitize NSCLC cells to cisplatin. Clin Transl Oncol. 2017;19:587–592.
   PubMed Web of Science ®Google Scholar
• Su YC, Chen YC, Tseng YL, et al. The pro-survival Oct4/Stat1/Mcl-1 axis is associated with poor prognosis in lung adenocarcinoma patients. 2021;10. DOI:10.3390/cells10102642
   Google Scholar
• Fang W, Ni M, Zhang M, et al. Prognostic value of OCT4 in colorectal cancer: analysis using immunohistochemistry and bioinformatics validation. Biomark Med. 2020;14:1473–1484.
   PubMed Web of Science ®Google Scholar
• Nathansen J, Lukiyanchuk V, Hein L, et al. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L. Oncogene. 2021;40:4214–4228.
   PubMed Web of Science ®Google Scholar
• Shao M, Bi T, Ding W, et al. OCT4 potentiates radio-resistance and migration activity of rectal cancer cells by improving epithelial-mesenchymal transition in a ZEB1 dependent manner. 2018;3424956. DOI:10.1155/2018/3424956
   Google Scholar
• Das Roy L, Curry JM, Sahraei M, et al. Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling. Bcr. 2013;15:R32.
   PubMed Web of Science ®Google Scholar
• Rojas A, Zhang P, Wang Y, et al. A positive TGF-β/c-KIT feedback loop drives tumor progression in advanced primary liver cancer. Neoplasia. 2016;18:371–386.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun T, Sun H, et al. SCF/C-Kit/JNK/AP-1 signaling pathway promotes Claudin-3 expression in colonic epithelium and colorectal carcinoma. Int J Mol Sci. 2017;18:10.3390/ijms18040765.
   Web of Science ®Google Scholar
• Zhang M, Ma Q, Hu H, et al. Stem cell factor/c-kit signaling enhances invasion of pancreatic cancer cells via HIF-1α under normoxic condition. Cancer Lett. 2011;303:108–117.
   PubMed Web of Science ®Google Scholar
• Li G, Yang S, Shen P, et al. Scf/c-KIT signaling promotes mucus secretion of colonic goblet cells and development of mucinous colorectal adenocarcinoma. Am J Cancer Res. 2018;8:1064–1073.
   PubMed Web of Science ®Google Scholar